logo-loader
viewWillow Biosciences Inc.

Willow Bioscience takes first major step towards development of pharmaceutical grade CBG

Willow Bioscience (TSE: WLLW: OTCQX: CANSF) CEO Trevor Peters joined Steve Darling from Proactive Vancouver with news the company has hit a major milestone in their development. Peters talks about this significant step. Peters also talked about the company as a whole and what separates them from others in their sector.

Quick facts: Willow Biosciences Inc.

Price: 0.7 CAD

TSX:WLLW
Market: TSX
Market Cap: $55.22 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

HANetf's Hector McNeil says price of gold is heading towards $3000 by year end

HANeft co-founder Hector McNeil talks to Proactive London's Katie Pilbeam about how the surge in gold above $2000 an ounce is benefiting his company. The platform's largest fund The Royal Mint Physical Gold ETC, which was launched in February has seen huge safe haven flows amid the...

4 hours, 48 minutes ago

2 min read